{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:34:26Z","timestamp":1791318866083,"version":"4.3.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM)"},{"DOI":"10.13039\/501100005737","name":"Universit\u00e9 Pierre et Marie Curie (UPMC, Paris 6)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005737","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Institut UPSA de la Douleur"},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale (FRM)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et de Th\u00e9rapeutique (SFPT)"},{"name":"UPSA"},{"name":"French Ministry of Research"},{"name":"SFPT"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.neuropharm.2012.07.023","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T10:17:39Z","timestamp":1342779459000},"page":"1093-1106","source":"Crossref","is-referenced-by-count":54,"title":["GABA, but not opioids, mediates the anti-hyperalgesic effects of 5-HT7 receptor activation in rats suffering from neuropathic pain"],"prefix":"10.1016","volume":"63","author":[{"given":"Florent","family":"Viguier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Michot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Kayser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Miguel","family":"Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Hamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Bourgoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.07.023_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchemneu.2011.11.002","article-title":"Descending projections from the rostral ventromedial medulla (RVM) to trigeminal and spinal dorsal horns are morphologically and neurochemically distinct","volume":"43","author":"Aicher","year":"2012","journal-title":"J.\u00a0Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0304-3940(95)12600-7","article-title":"The role of 5-HT3 receptors in nociceptive processing in the rat spinal cord: results from behavioural and electrophysiological studies","volume":"208","author":"Ali","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.pbb.2011.06.005","article-title":"Blockade of 5-HT7 receptors reduces tactile allodynia in the rat","volume":"99","author":"Amaya-Castellanos","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neulet.2010.08.024","article-title":"Descending serotonergic facilitation mediated by spinal 5-HT3 receptors engages spinal rapamycin-sensitive pathways in the rat","volume":"484","author":"Asante","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/FBP.0b013e328349aae4","article-title":"The complex role of serotonin and 5-HT receptors in chronic pain","volume":"22","author":"Bardin","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1212\/WNL.0b013e3181e8e984","article-title":"Central neuron-glia interactions and neuropathic pain. Overview of recent concepts and clinical implications","volume":"75","author":"Benarroch","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A\u00a0peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1152\/physrev.1987.67.1.67","article-title":"Peripheral and spinal mechanisms of nociception","volume":"67","author":"Besson","year":"1987","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.neuron.2012.02.033","article-title":"Forebrain GABAergic neuron precursors integrate into adult spinal cord and reduce injury-induced neuropathic pain","volume":"74","author":"Braz","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pain.2008.11.009","article-title":"5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice","volume":"141","author":"Brenchat","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pain.2010.03.007","article-title":"Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity","volume":"149","author":"Brenchat","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejpain.2011.07.004","article-title":"Role of peripheral versus spinal 5-HT7 receptors in the modulation of pain under sensitizing conditions","volume":"16","author":"Brenchat","year":"2012","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib13","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/sj.bjp.0704813","article-title":"Evidence for a GABA(b) receptor component in the spinal action of substance P (SP) on arterial blood pressure in the awake rat","volume":"136","author":"Brouillette","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.brainres.2006.01.053","article-title":"Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids","volume":"1081","author":"Chen","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0304-3959(00)00334-1","article-title":"The development of pain-related behaviour and opioid tolerance after neuropathy-inducing surgery and sham surgery","volume":"88","author":"Christensen","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrn894","article-title":"How do you feel? Interoception: the sense of the physiological condition of the body","volume":"3","author":"Craig","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.coph.2006.11.005","article-title":"Altered chloride homeostasis in neurological disorders: a new target","volume":"7","author":"De Koninck","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3171\/jns.1985.62.3.0397","article-title":"Pain suppression induced by electrical stimulation of the pontine parabrachial region. Experimental study in cats","volume":"62","author":"DeSalles","year":"1985","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/PL00005359","article-title":"Changes in systemic and regional hemodynamics during 5-HT7 receptor-mediated depressor responses in rats","volume":"359","author":"De Vries","year":"1999","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/sj.bjp.0706854","article-title":"Systemic morphine produces antinociception mediated by spinal 5-HT7, but not 5-HT1A and 5-HT2 receptors in the spinal cord","volume":"149","author":"Dogrul","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib21","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.brainres.2009.05.001","article-title":"Differential mediation of descending pain facilitation and inhibition by spinal 5-HT3 and 5-HT7 receptors","volume":"1280","author":"Dogrul","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cne.20667","article-title":"Pre- and postsynaptic localization of the 5-HT7 receptor in rat dorsal spinal cord: immunocytochemical evidence","volume":"490","author":"Doly","year":"2005","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pain.2010.06.019","article-title":"The evidence for pharmacological treatment of neuropathic pain","volume":"150","author":"Finnerup","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib24","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1152\/jn.91160.2008","article-title":"Facilitatory actions of serotonin type 3 receptors on GABAergic inhibitory synaptic transmission in the spinal superficial dorsal horn","volume":"102","author":"Fukushima","year":"2009","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1152\/jn.00377.2006","article-title":"GABAA-Receptor blockade reverses the injury-induced sensitization of nociceptor-specific (NS) neurons in the spinal dorsal horn of the rat","volume":"96","author":"Garcia-Nicas","year":"2006","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1113\/eph8702357","article-title":"Pain pathways and parabrachial circuits in the rat","volume":"87","author":"Gauriau","year":"2002","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.pain.2010.12.020","article-title":"Role of peripheral 5-HT4, 5-HT6 and 5-HT7 receptors in development and maintenance of secondary mechanical allodynia and hyperalgesia","volume":"152","author":"Godinez-Chaparro","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib28","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1089\/neu.2006.23.1111","article-title":"Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury","volume":"23","author":"Gwak","year":"2006","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.pain.2004.11.023","article-title":"Activation of 5-HT1A and 5-HT7 receptors in the parafascicular nucleus suppresses the affective reaction of rats to noxious stimulation","volume":"113","author":"Harte","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0006-8993(84)90089-1","article-title":"Bilateral lesions of the dorsolateral funiculus of the cat spinal cord: effects on basal nociceptive reflexes and nociceptive suppression produced by cholinergic activation of the pontine parabrachial region","volume":"311","author":"Hayes","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0006-8993(84)90717-0","article-title":"Evidence for involvement of cholinoceptive cells of the parabrachial region in environmentally induced nociceptive suppression in the cat","volume":"299","author":"Katayama","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0006-8993(03)02952-4","article-title":"The activation of 5-HT3 receptors evokes GABA release in the spinal cord","volume":"978","author":"Kawamata","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0006-8993(86)90807-3","article-title":"Analgesia produced by low doses of the opiate antagonist naloxone in arthritic rats is reduced in morphine-tolerant animals","volume":"371","author":"Kayser","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib34","series-title":"Pharmacology of Pain","first-page":"185","article-title":"Toward deciphering the respective roles of multiple 5-HT receptors in the complex serotonin-mediated control of pain","author":"Kayser","year":"2010"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3959(02)00497-9","article-title":"Effects of the novel analgesic, cizolirtine, in a rat model of neuropathic pain","volume":"104","author":"Kayser","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib36","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.neuropharm.2009.09.003","article-title":"Differential anti-neuropathic pain effects of tetrodotoxin in sciatic nerve- versus infraorbital nerve-ligated rats\u2013behavioral, pharmacological and immunohistochemical investigations","volume":"58","author":"Kayser","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib37","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature06493","article-title":"Reversal of pathological pain through specific spinal GABAA receptor subtypes","volume":"451","author":"Knabl","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib38","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1523\/JNEUROSCI.2552-08.2008","article-title":"Differential implication of proinflammatory cytokine interleukin-6 in the development of cephalic versus extracephalic neuropathic pain in rats","volume":"28","author":"Latr\u00e9moli\u00e8re","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01514-X","article-title":"Animal models of nociception","volume":"53","author":"Le Bars","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4196\/kjpp.2010.14.2.59","article-title":"Are spinal GABAergic elements related to the manifestation of neuropathic pain in rat?","volume":"14","author":"Lee","year":"2010","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2010.08.013","article-title":"Serotonin 5-HT7 receptor agents: structure-activity relationships and potential therapeutic applications in central nervous system disorders","volume":"129","author":"Leopoldo","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib42","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1471-4159.2005.03079.x","article-title":"Serotonin via 5-HT7 receptors activated p38 mitogen-activated protein kinase and protein kinase C\u025b resulting in interleukin-6 synthesis in human U373 MG astrocytoma cells","volume":"93","author":"Lieb","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuropharm.2005.01.025","article-title":"Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells","volume":"49","author":"Mah\u00e9","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib44","article-title":"Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives","author":"Matthys","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/1056-8719(94)90087-6","article-title":"A\u00a0method to perform direct transcutaneous intrathecal injection in rats","volume":"32","author":"Mestre","year":"1994","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib46","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0024-3205(02)02011-8","article-title":"5-HT7 receptors are involved in mediating 5-HT-induced activation of rat primary afferent neurons","volume":"71","author":"Meuser","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","article-title":"Descending control of pain","volume":"66","author":"Millan","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib48","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tips.2009.06.004","article-title":"Developing analgesics by enhancing spinal inhibition after injury: GABAA receptor subtypes as novel targets","volume":"30","author":"Munro","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0891-0618(00)00092-2","article-title":"Localization of 5-HT7 receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression","volume":"21","author":"Neumaier","year":"2001","journal-title":"J.\u00a0Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib50","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1476-5381.2009.00410.x","article-title":"Evidence that 5-hydroxytryptamine7 receptors play a role in the mediation of afferent transmission within the nucleus tractus solitarius in anaesthetized rats","volume":"158","author":"Oskutyte","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib51","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2005"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib52","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4522(95)00329-0","article-title":"5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study","volume":"70","author":"Pierce","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib53","first-page":"409","article-title":"A\u00a0method for measurement of analgesic activity on inflamed tissue","volume":"111","author":"Randall","year":"1957","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib54","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1185\/03007995.2011.611494","article-title":"Systemic review of tapentadol in chronic severe pain","volume":"27","author":"Riemsma","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib55","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.pain.2005.06.011","article-title":"Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test","volume":"117","author":"Rocha-Gonzalez","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib56","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib57","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tips.2004.10.002","article-title":"Bad news from the brain: descending 5-HT pathways that control spinal pain processing","volume":"25","author":"Suzuki","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib58","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1213\/00000539-200206000-00031","article-title":"The role of spinal opioid receptors in antinociceptive effects produced by intrathecal administration of hydromorphone and buprenorphine in the rat","volume":"94","author":"Tejwani","year":"2002","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0304-3940(01)01617-2","article-title":"5-HT7 receptor mRNA expression in human trigeminal ganglia","volume":"302","author":"Terron","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib60","first-page":"535","article-title":"5-HT7 receptors modulate GABAergic transmission in rat hippocampal CA1 area","volume":"62","author":"Tokarski","year":"2011","journal-title":"J.\u00a0Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib61","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1523\/JNEUROSCI.14-05-02708.1994","article-title":"Behavioural evidence of trigeminal neuropathic pain following chronic constriction injury to rat's infraorbital nerve","volume":"14","author":"Vos","year":"1994","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib62","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bbi.2009.12.007","article-title":"Dynamic regulation of spinal pro-inflammatory cytokine release in the rat in\u00a0vivo following peripheral nerve injury","volume":"24","author":"Whitehead","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib63","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/ALN.0b013e3181cd7920","article-title":"Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, o-desmethyltramadol, via activation of descending serotonergic pathways","volume":"112","author":"Yanarates","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2012.07.023_bib64","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1523\/JNEUROSCI.22-03-01010.2002","article-title":"The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors","volume":"22","author":"Zeitz","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.023_bib65","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812003590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812003590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T22:09:00Z","timestamp":1743804540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812003590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0028390812003590"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.07.023","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}